Publications by authors named "Bahram Forouzesh"

Claim this Profile
P
Phase I, pharmacokinetic study of temsirolimus administered orally to patients with advanced cancer.
Jan C Buckner, Bahram Forouzesh, Charles Erlichman, Manuel Hidalgo, Joseph P Boni

Invest New Drugs· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of sequential paclitaxel and trabectedin every 2 weeks in patients with advanced solid tumors.
Quincy Chu, Alain Mita, Bahram Forouzesh, Anthony W Tolcher, Gary Schwartz

Clin Cancer Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of trabectedin as a 1- or 3-hour infusion weekly in patients with advanced solid malignancies.
Bahram Forouzesh, Manuel Hidalgo, Quincy Chu, Alain Mita, Monica Mita

Clin Cancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors.
Alain C Mita, Louis J Denis, Eric K Rowinsky, Johann S Debono, Andrew D Goetz, Bahram Forouzesh

Clin Cancer Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas.
Quincy S C Chu, Bahram Forouzesh, Samira Syed, Monica Mita, Garry Schwartz

Invest New Drugs· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer.
Chris H Takimoto, Lisa A Hammond-Thelin, Jane E Latz, Leonardo Forero, Muralidhar Beeram, Bahram Forouzesh

Clin Cancer Res· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of sequences of the rebeccamycin analogue NSC 655649 and cisplatin in patients with advanced solid tumors.
Alejandro D Ricart, Lisa A Hammond, John G Kuhn, Chris H Takimoto, Andrew Goetz, Bahram Forouzesh

Clin Cancer Res· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies.
Bahram Forouzesh, Chris H Takimoto, Andrew Goetz, Sami Diab, Lisa A Hammond

Clin Cancer Res· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignancies.
Eric K Rowinsky, Jinee Rizzo, Leonel Ochoa, Chris H Takimoto, Bahram Forouzesh

J Clin Oncol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis